| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.18 | 0.0007 |